Clinical Trials · NCT06408532
The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Peking University People's Hospital
- Enrollment
- 256
- Start date
- Apr 2024
- Locations
- See registry
- Primary endpoint
- Hemoglobin A1c (HbA1c)